Clinical trials
Blood Cancer clinical trials
Below are recruiting blood cancer clinical trials, each written for real people, not researchers. We’re tracking 462 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07098182Recruiting
Preserving blood supply during colon or rectal surgery
This trial tests a technique during colon or rectal surgery to preserve a specific blood vessel (the left colic artery) that helps keep the remaining colon healthy. It is for people with left colon, rectal, or ovarian cancer who are scheduled for surgery.
Montpellier, HeraultAges 18 years+ - NCT06054854Recruiting
Lung Cancer Biomarker Study (BIRD Biobank)
This study collects blood, tissue, and other samples from people with lung nodules, suspected lung cancer, or confirmed lung cancer to find better ways to diagnose and treat the disease. By joining, you help researchers discover new biomarkers that could improve care for future patients.
ToulouseAges 18 years+ - NCT07439991Recruiting
Study of blood clot risks after lung cancer surgery
This study looks at why some people develop blood clots after lung cancer surgery. By tracking your recovery for 30 days, researchers hope to find better ways to predict and prevent clots in the future.
Changchun, JilinAges 18 years+ - NCT06274515RecruitingPhase 4
Study of resistance to breast cancer therapies
This study looks at why some breast cancers stop responding to treatment. It involves taking a small sample of your tumor (biopsy) and blood to understand resistance. If you have HER2-positive or triple-negative breast cancer that is growing despite treatment, you may be able to join.
AnderlechtAges 18 years+ - NCT01048281Recruiting
Study of stomach and esophagus cancer samples
This study looks at stomach (gastric) and esophagus cancer, using clinical information and tissue samples. It may help researchers better understand these cancers and improve future care.
Stanford, CaliforniaAges 18 years+ - NCT07195344RecruitingPhase 4
T-DXd for breast cancer: comparing drug levels by BMI
This trial studies how the drug T-DXd (trastuzumab-deruxtecan) works in people with advanced or metastatic breast cancer. It compares drug levels in the body based on body mass index (BMI) to see if dose adjustments are needed.
AngersAges 18 years+ - NCT05577143Recruiting
Blood test screening for colorectal cancer
This study checks whether a blood test can help identify colorectal cancer or precancerous growths. You would have a planned colonoscopy, and researchers compare the blood test results to what the colonoscopy finds.
LilleAges 18–75 - NCT07543159Recruiting
Blood and tissue sample collection for medical research
This study collects blood, tissue, or other samples from people with various conditions—including cancer, infections, autoimmune diseases, or healthy volunteers—to help researchers understand these diseases better. Your samples will be stored and used for future medical research.
Shirley, New YorkAges 18 years+ - NCT05497531Recruiting
Test blood DNA to help guide liver and pancreas biopsies
This pilot study checks whether a special blood test (ctDNA) can detect cancer signals and work as well as another sample method during biopsies for liver, bile duct, or pancreatic cancers. It may help doctors choose the best way to confirm the diagnosis from biopsy samples.
Orange, CaliforniaAges 18 years+ - NCT07310537Recruiting
Liquid biopsy trial for colorectal cancer liver metastases
This study tests whether a simple blood sample from your finger can detect tumor DNA as well as a standard blood draw. It is designed for people with colorectal cancer that has spread to the liver and hasn't responded to treatment.
Rotterdam, South HollandAges 21 years+ - NCT07182214Recruiting
Lung cancer detection using a blood test for early signs
This study uses a blood test to look for tiny genetic markers (miRNA and DNA methylation) that may help detect lung cancer early. If you have a lung nodule or mass found on a CT scan and haven't had treatment yet, you may be able to join.
HsinchuAges 18 years+ - NCT06778512Recruiting
Lung nodule study: using CT scans and breathing tests
This study looks at lung nodules found on CT scans. Researchers will collect data from your breathing tests and CT scans to better understand how these nodules relate to lung cancer.
Guangzhou, GuangdongAges 18–75 - NCT07707245Recruiting
Finding biomarkers in lung disease and lung cancer
This trial studies blood and tissue samples from people with COPD, IPF, or lung cancer to find markers that can help diagnose and predict these conditions. It aims to discover why some lung diseases progress to cancer.
Milan, MilanAges 18 years+ - NCT06640959Recruiting
Bowel health study for prostate cancer radiation
This study tests whether a daily drink can help reduce bowel side effects caused by radiation for prostate cancer. If you are about to start radiation for intermediate to high-risk prostate cancer, you may be able to join.
Manchester, Greater ManchesterAges 18 years+ - NCT04374175Recruiting
Blood sample bank for pancreatic cancer patients and controls
This study collects and stores blood samples (“serum bank”) from people with pancreatic cancer and from comparison participants. The goal is to help researchers study the disease and improve future diagnosis or treatment planning.
Saint-EtienneAges 18 years+ - NCT07260370Recruiting
Studying blood markers in cancer patients on immunotherapy
This study looks at tiny particles (microRNA) and cancer cells in the blood of people with cancer who are getting immunotherapy. It aims to find patterns that might help doctors better understand how the treatment is working.
Taoyuan CityAges 20 years+ - NCT06864481Recruiting
Study of liver inflammation from immunotherapy drugs
This study follows people who develop liver inflammation (hepatitis) after starting immunotherapy for cancer. It helps doctors understand how often this happens and how to manage it.
MontpellierAges 18 years+ - NCT03758976Recruiting
Study of scans in advanced breast cancer recurrence
This study looks at people with advanced breast cancer to better understand recurrence by using information from recent scans. It may help researchers improve how advanced disease is assessed and followed over time.
LundAges 18 years+ - NCT05754892Recruiting
Using tumor lab markers during adrenal cancer care
This trial studies how to use lab tests (“molecular markers”) in routine clinical care to help manage people with adrenal tumors that could be cancerous. If you are having surgery soon (or recently), your tissue may be tested to see if these markers improve decision-making for your care.
ParisAges 18 years+ - NCT03207854Recruiting
Donate blood and immune samples for cancer, blood, or healthy volunteers study
This study collects blood and immune-related samples from people with cancer, certain immune-related blood conditions, or healthy volunteers. It helps researchers understand immune changes and may support future diagnosis or treatments.
Los Angeles, CaliforniaAges 19 years+ - NCT03017573Recruiting
Cancer biobank study linking tumor, immune system, and environment
This study collects tumor and related samples from people with certain newly diagnosed cancers. Researchers use these samples to better understand how cancer cells, the surrounding tissue, and the immune system interact, which may guide better future treatments.
BordeauxAges 18 years+ - NCT05132244Recruiting
Monitoring blood sugar levels in people starting pancreatic cancer treatment
This study looks at how well blood sugar (glucose) levels can be monitored and managed in people with pancreatic cancer who are starting their first treatment. It aims to understand if careful glucose management can improve well-being and possibly treatment outcomes.
Vancouver, British ColumbiaAges 18 years+ - NCT03869814Recruiting
Blood test to study cancer signals without invasive procedures
This study looks at a non-invasive blood test to detect cancer-related “signal patterns” and see how well they match different types of cancer. It may help researchers learn better ways to find or understand cancer using less invasive testing.
San Diego, CaliforniaAges 21–80 - NCT00900497Enrolling by invitationPhase 1/Phase 2
Donor white blood cells to treat solid tumors
This Phase 1/2 study tests whether donated white blood cells (granulocytes) from healthy donors can help treat solid cancers that cannot be cured or have stopped responding to standard treatments. The goal is to see safety first, and then whether the treatment can shrink or control tumors.
Boynton Beach, FloridaAges 18 years+
Hear when a new Blood Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for blood cancer?
- Yes. Clin2 currently lists 462 recruiting blood cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a blood cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a blood cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.